iSpecimen, Inc. (ISPC)

NASDAQ: ISPC · IEX Real-Time Price · USD
-0.01 (-0.60%)
At close: Sep 30, 2022 4:00 PM
-0.07 (-4.24%)
After-hours: Sep 30, 2022 5:30 PM EDT

Total Valuation

iSpecimen has a market cap or net worth of $14.65 million. The enterprise value is -$5.35 million.

Market Cap 14.65M
Enterprise Value -5.35M

Important Dates

The latest earnings date was Thursday, August 4, 2022, before market open.

Last Earnings Date Aug 4, 2022
Ex-Dividend Date n/a

Share Statistics

iSpecimen has 8.88 million shares outstanding. The number of shares has increased by 447.33% in one year.

Shares Outstanding 8.88M
Shares Change (YoY) +447.33%
Shares Change (QoQ) +0.64%
Owned by Insiders (%) 30.25%
Owned by Institutions (%) 4.65%
Float 6.13M

Valuation Ratios

PE Ratio 0.78
Forward PE n/a
PS Ratio 1.45
Forward PS 1.19
PB Ratio 0.58
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.37, with a Debt / Equity ratio of 0.15.

Current Ratio 13.37
Quick Ratio 13.11
Debt / Equity 0.15
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -36.20% and return on invested capital (ROIC) is -138.90%.

Return on Equity (ROE) -36.20%
Return on Assets (ROA) -29.40%
Return on Capital (ROIC) -138.90%
Revenue Per Employee $171,610
Profits Per Employee -$145,660
Employee Count 59
Asset Turnover 0.35
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
Total Price Change -73.17%
50-Day Moving Average 2.10
200-Day Moving Average 2.78
Average Volume (30 Days) 404,306

Short Selling Information

The latest short interest is 106,657, so 1.20% of the outstanding shares have been sold short.

Short Interest 106,657
Short % of Shares Out 1.20%
Short % of Float 1.74%
Short Ratio (days to cover) 1.82

Income Statement

In the last 12 months, iSpecimen had revenue of $10.12 million and -8.59 million in losses. Earnings per share was $2.11.

Revenue 10.12M
Gross Profit 5.82M
Operating Income -8.20M
Net Income -8.59M
EBIT -8.40M
Earnings Per Share (EPS) $2.11
Full Income Statement

Balance Sheet

The company has $23.69 million in cash and $3.69 million in debt, giving a net cash position of $20.00 million or $2.25 per share.

Cash & Cash Equivalents 23.69M
Total Debt 3.69M
Net Cash 20.00M
Net Cash Per Share $2.25
Book Value 25.30M
Book Value Per Share 2.85
Working Capital 25.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.75 million and capital expenditures -$1.37 million, giving a free cash flow of -$12.13 million.

Operating Cash Flow -10.75M
Capital Expenditures -1.37M
Free Cash Flow -12.13M
FCF Per Share n/a
Full Cash Flow Statement


Gross margin is 57.51%, with operating and profit margins of -81.02% and -84.88%.

Gross Margin 57.51%
Operating Margin -81.02%
Pretax Margin n/a
Profit Margin -84.88%
EBITDA Margin -82.62%
EBIT Margin -82.94%
FCF Margin -119.76%

Dividends & Yields

iSpecimen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -58.65%
FCF Yield -82.75%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -447.33%
Shareholder Yield -447.33%
Dividend Details

Analyst Forecast

The average price target for iSpecimen is $10.03, which is 507.88% higher than the current price. The consensus rating is "Buy".

Price Target $10.03
Price Target Difference 507.88%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a